Cell Differentiation, Stem Cells, and Reprogramming- Lectures 58 and 59 Flashcards

1
Q

What is a differentiated cell?

A

cells the have a specific set of genes expressed that are unique to the kind of cell it is

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the steps on the way to a fully differentiated cell?

A

uncommitted precursor cell
determination (cell becomes committed to a single lineage and acquires the competence to undergo terminal differentiation)
differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Outline the events associated with myoblast differentiation.

A

exit from cell cycle
expression of muscle-specific genes
fusion to form multinucleated myotubes
expression of ACh receptors and other proteins of the neuromuscular junction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the roles in sequence of the MyoD family of muscle regulatory factors.

A

Myf5 and MyoD are used for determination (somitic cell to myoblast)
MyoD myogenin and MRF4 are used for differentiation (myoblast to terminally differentiated myofiber)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Desribe the pathway of positive feedback in transcriptional regulation of myoblast differentiation.

A

Myogenic inducers (eg. Wnt, Shh) added –>
transcription activation of Myf5 and MyoD whose proteins activate Myogenin transcription, the product of which activates Mef2 whose product activates itself and myogenin
MyoD, Myog, and Mef2 all activate muscle-specific terminal differentiation genes (eg. Mck)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe what happens when cultured myoblasts are switched to a depleted growth factor environment.

A
  1. decrease in cyclin D1/Cdk4 activity –> decrease in phospho-pRb –> cell cycle exit
  2. increase in MyoD transcriptional activity –> increase in p21 expression –> decrease in cyclin E/Cdk2 activity –> decrease in phospho-pRb –> cell cycle exit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are stem cells?

A

cells that can self-renew and generate differentiated cell types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are adult stem cells?

A

responsible for homeostatic maintenance and repair to injury (eg. hematopoietic stem cells; skeletal muscle satellite cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are embryonic stem cells (ES)?

A

cells derived from the inner cell mass of the blastocyst that have been placed into culture and can divide indefinitely and differentiate into all lineages of the three germ layers in vitro and in vivo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is unipotency?

A

the ability to form a single cell type or lineage (eg. testes stem cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is multipotency?

A

the ability to give rise to multiple cell types (eg. hematopoetic stem cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is pluripotency?

A

the ability to give rise to all the cells of an organism, EXCLUDING extraembryonic tissues (eg. ES cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is somatic cell nuclear transfer (SCNT)?

A

transfer of a somatic nucleus into an enucleated oocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is reproductive cloning?

A

generation of a new organism following SCNT or other means

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is therapeutic cloning?

A

generation of a blastocyst following SCNT from which ES cells are isolated and used as a source of differentiated cells for therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are induces pluripotent (iPS) cells?

A

reprogramming of somatic cells into an ES cell-like phenotype by expression of pluripotency genes (Oct4, Sox2, Nanog, c-myc)

17
Q

What are some challenges of application of pluripotency reprogramming as a therapeutic tool?

A
  1. potential oncogenicity of required factors
  2. vectors (viruses can cause insertional mutations)- though this can be overcome by transient expression of Yamanaka factors via several different mechanisms
  3. low efficiency
  4. potential acquisition of genetic changes during the generation of iPS cells (not the largest problem)
18
Q

Describe one application of these new technologies in pluripotency reprogramming as a therapeutic tool.

A
epidermolysis bullosa (junctional, simplex, or dystrophic blistering disease of the skin)
successful transplant of viral laminin (mixture of cell and gene therapy) that improved disease after application of lab grown skin to patient's affected areas
19
Q

What is todipotency?

A

property of zygotes where they can form all cells of the body as well as extraembryonic structures such as the placenta